Kara Spiller | URBN Professor of Biomedical Innovation
Drexel University

Kara Spiller, URBN Professor of Biomedical Innovation, Drexel University

Dr. Kara Spiller is the URBN Endowed Professor of Biomedical Innovation in Drexel University's School of Biomedical Engineering, Science, and Health Systems. Her research focuses on the role of immune cells in tissue repair and regeneration and the design of immunomodulatory biomaterials. Her research is funded by the NIH, the NSF, private foundations, and industry. Her awards include a Fulbright fellowship, the NSF CAREER award, and the United States Dept. of State ASPIRE prize. She has published more than 80 publications in biomaterials and immune engineering, and has 18 issued or pending patents. She is the founding director of the Immune Modulation & Engineering Symposium series in Philadelphia, which is the only annually recurring meeting dedicated to convergent research in translational immunology and engineering, and she directs multiple undergraduate and graduate programs focused on advanced therapeutics at Drexel University. She serves on the board of numerous journals and is a frequent ad hoc study section member.

Appearances:



Advanced Therapies USA 2025 - Day 2 @ 13:25

Engineered macrophage cell therapy with streamlined manufacturing

last published: 28/May/25 08:55 GMT

back to speakers

Get Involved with the Advanced Therapies Congress

 

To sponsor or exhibit


Natasha Bangle
natasha.bangle@terrapinn.com
+44 20 3545 5515


Joshua Lloyd
Josh.Lloyd@terrapinn.com
+44 20 4614 9423

 

To speak


Chris Shanks
chris.shanks@terrapinn.com
+44 20 8152 7604